Neuroone Medical Technologies (NMTC) Cost of Revenue (2011 - 2026)
Neuroone Medical Technologies (NMTC) posted Cost of Revenue of $216659.0 for Q1 2026, down 15.72% on a QoQ basis from $257082.0 in Q4 2025, and up 37.62% year-over-year from $157436.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Cost of Revenue (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies' Cost of Revenue history runs 8 years deep, the most recent figure standing at $216659.0 for Q1 2026.
- Quarterly Cost of Revenue rose 37.62% year-over-year to $216659.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 137.81% YoY) and the FY2025 annual result came in at $4.0 million, up 66.7% from the prior year.
- Cost of Revenue was $216659.0 for Q1 2026 at Neuroone Medical Technologies, down from $257082.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $1.2 million in Q3 2025 and bottomed at $38462.0 in Q2 2022.
- A 5-year average of $405528.9 and a median of $257082.0 in 2025 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue soared 904.21% — and 2025, when it slumped 84.05%.
- Neuroone Medical Technologies' Cost of Revenue stood at $126886.0 in 2022, then surged by 460.61% to $711335.0 in 2023, then sank by 71.19% to $204916.0 in 2024, then rose by 25.46% to $257082.0 in 2025, then dropped by 15.72% to $216659.0 in 2026.
- Business Quant data shows NMTC's Cost of Revenue at $216659.0 in Q1 2026, $257082.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Neuroone Medical Technologies | 14.85 Mn | 12.05 Mn | 990,264.00 | 216,659.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,659.00 |
| Mar 31, 2026 | 216,659.00 |
| Dec 31, 2025 | 257,082.00 |
| Dec 31, 2025 | 257,082.00 |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 781,215.00 |
| Jun 30, 2025 | 781,215.00 |
| Mar 31, 2025 | 157,436.00 |
| Mar 31, 2025 | 157,436.00 |
| Dec 31, 2024 | 204,916.00 |
| Dec 31, 2024 | 204,916.00 |
| Sep 30, 2024 | 131,222.00 |
| Sep 30, 2024 | 131,222.00 |
| Jun 30, 2024 | 543,904.00 |
| Jun 30, 2024 | 543,904.00 |
| Mar 31, 2024 | 986,875.00 |
| Mar 31, 2024 | 986,875.00 |
| Dec 31, 2023 | 711,335.00 |
| Dec 31, 2023 | 711,335.00 |